From P-E Country
Bright Horizons Family Solutions plans to price 10.1 million shares at $19 to $21 each on Thursday evening. The IPO is expected to start trading Friday morning on the New York Stock Exchange under the proposed symbol “BFAM.” The joint-lead managers are Goldman Sachs, J.P. Morgan and Barclays. The co-managers are BofA Merrill Lynch, Credit Suisse, Baird, BMO Capital Markets, Stifel Nicolaus Weisel and SMBC Nikko.
Based in Watertown, Massachusetts, Bright Horizons provides child care, early education services and other services to more than 87,000 children in about 775 centers in the United States, Britain, the Netherlands, Ireland, Canada and India. Formed in 1986, Bright Horizons is a leading provider of employer-sponsored child care. The company has about 2,200 employees.
Bright Horizons was a publicly traded company on NASDAQ from 1998 until May 2008 when Bain Capital acquired it for a reported $1.3 billion.
Bright Horizons plans to sell all of the shares in the offering and expects to have about 62.9 million shares outstanding after the offering.
Back From 2002
LipoScience plans to price 5 million shares at $13 to $15 each on Thursday evening. The IPO is expected to start trading Friday morning on the NASDAQ Global Market under the proposed symbol “LPDX.” The joint-lead managers are Barclays, UBS Investment Bank and Piper Jaffray.
Based in Raleigh, North Carolina, LipoScience is a diagnostic company advancing patient care in detecting cardiovascular, metabolic and other diseases using its innovative and proprietary technology platform based on nuclear magnetic resonance. LipoScience was formed in 1994. It has about 204 employees.
Among the company’s major risk factors, according to its prospectus, are:
“Although we generated net income for the nine months ended September 30, 2012, we incurred a net loss of $0.5 million for the year ended December 31, 2011 and have incurred significant losses since our inception. As of September 30, 2012, we had an accumulated deficit of $48.2 million. We anticipate experiencing losses for the next several years as we increase expenses in pursuit of our growth strategy and our efforts to increase market share for the NMR LipoProfile test, place the Vantera system in third-party clinical diagnostic laboratories, and develop new personalized diagnostic tests.”
LipoScience plans to sell all of the shares in the offering. It expects to have about 13.9 million shares outstanding after the offering.
On March 1, 2002, LipoScience filed for an IPO to raise $100 million. On Sept. 17, 2002, the company set pricing terms to offer 5 million shares at $14 to $16 each; it withdrew the offering on Oct. 21, 2002.
A Look at a 2012 Rollover
Renewable Energy Group (REGI) believes it is the largest producer of biodiesel in the United States. It priced its IPO of 7.2 million shares at $10 each on Jan. 17, 2012. The stock closed on Friday, Jan. 18, at $6.42, DOWN 35.8 percent from its initial offering price.
That will bring us to next week with a calendar of five IPOs. They are expecting to raise over $2.2 billion.
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.